Veterinary Sciences, 2023 The gastrointestinal microbiota plays an important role in health of the host animals and the detrimental influence of pharmaceutical treatment on the fecal microbiota receives an increasing concern.
Xinyi Ma +7 more
doaj +1 more source
Comparative effect of dose escalation of nanocapsulated ivermectin against mange in rabbits
German Journal of Veterinary Research, 2022 The present study aimed to investigate the effects of nano-capsulated ivermectin on the liver and kidney function and oxidative status in mite infested-rabbits, compared to ivermectin. Additionally, the ivermectin residue profile in adipose tissue, liver,
Azza Abdelmoteleb +3 more
doaj +1 more source
South African Medical Journal, 2022 Background. Ivermectin is an antiparasitic drug that has shown in vitro activity against COVID‑19. Clinical studies supporting ivermectin for COVID‑19 prevention and treatment are conflicting, with important limitations. Public support for ivermectin is
V Pillay-Fuentes Lorente +8 more
doaj +1 more source
Nematode control in suckler beef cattle over their first two grazing seasons using a targeted selective treatment approach [PDF]
, 2015 peer-reviewedBackground With concerns over the development of anthelmintic resistance in cattle nematode populations, we must re-examine our approach to nematode control in cattle.
Barrett, Damien +6 more
core +1 more source
The transcriptional response of Caenorhabditis elegans to ivermectin exposure identifies novel genes involved in the response to reduced food intake [PDF]
, 2012 We have examined the transcriptional response of Caenorhabditis elegans following exposure to the anthelmintic drug ivermectin (IVM) using whole genome microarrays and real-time QPCR.
A Etter +59 more
core +7 more sources
Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
Microorganisms, 2022 Ivermectin, an FDA-approved antiparasitic drug, has been reported to have in vitro activity against SARS-CoV-2. Increased off-label use of ivermectin for COVID-19 has been reported.
Caroline S. Foo +6 more
doaj +1 more source
Modelling the consequences of targeted selective treatment strategies on performance and emergence of anthelmintic resistance amongst grazing calves [PDF]
, 2016 The development of anthelmintic resistance by helminths can be slowed by maintaining refugia on pasture or in untreated hosts. Targeted selective treatments (TST) may achieve this through the treatment only of individuals that would benefit most from ...
Berk, Zoe +3 more
core +2 more sources
Early-life exposure to Ivermectin alters long-term growth and disease susceptibility.
PLoS ONE, 2021 Ivermectin is a broad-spectrum antiparasitic medicine, which is often used as a treatment for parasites or as a prophylaxis. While studies have looked at the long-term effects of Ivermectin on helminths, studies have not considered the long-term impacts ...
Taegan A McMahon +2 more
doaj +1 more source
Ivermectin for onchocercal eye disease (river blindness).
, 2012 BACKGROUND: It is believed that ivermectin (a microfilaricide) could prevent blindness due to onchocerciasis. However, when given to everyone in communities where onchocerciasis is common, the effects of ivermectin on lesions affecting the eye are ...
Ejere, Henry OD +3 more
core +1 more source
, 2020 Discussion of scholar papers published on Ivermectin and of some news that we can find about its use for Covid-19. A list of clinical trials is also given. The discussion was made in a series of versions from 14 June to 27 July 2020. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedRχiv, which concludes that ...
openaire +13 more sources